Clinical Trial 43878

Tulsa, OK 74136


Summary:

To evaluate the short-term efficacy and safety of brexpiprazole monotherapy in treatment adolescents with schizophrenia.


Qualified Participants Must:

• Male or Female ages 13 to 17
• Has a clinical diagnosis of adolescent schizophrenia
• Have symptoms for at least 6 months prior to the first visit (i.e. hallucinations, dillusions)


Qualified Participants May Receive:

May receive compensation for travel and time 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.